ABSTRACT: Distinct mechanisms have evolved to regulate the function of proteolytic enzymes. Viral proteases in particular have developed novel regulatory mechanisms, presumably due to their comparatively rapid life cycles and responses to constant evolutionary pressure. Herpesviruses are a family of human pathogens that require a viral protease with a concentration-dependent zymogen activation involving folding of two R-helices and activation of the catalytic machinery, which results in formation of infectious virions. Kaposi's sarcoma-associated herpesvirus protease (KSHV Pr) is unique among the herpesvirus proteases in possessing an autolysis site in the dimer interface, which removes the carboxyl-terminal 27 amino acids comprising an R-helix adjacent to the active site. Truncation results in the irreversible loss of dimerization and concomitant inactivation. We characterized the conformational and functional differences between the active dimer, inactive monomer, and inactive truncated protease to determine the different protease regulatory mechanisms that control the KSHV lytic cycle. Circular dichroism revealed a loss of 31% R-helicity upon dimer dissociation. Comparison of the full-length and truncated monomers by NMR showed differences in 21% of the protein structure, mainly located adjacent to the dimer interface, with little perturbation of the overall protein upon truncation. Fluorescence polarization and active site labeling, with a transition state mimetic, characterized the functional effects of these conformational changes. Substrate turnover is abolished in both the full-length and truncated monomers; however, substrate binding remained intact. Disruption of the helix 6 interaction with the active site oxyanion loop is therefore used in two independent regulatory mechanisms of proteolytic activity.
The nine known human herpesviruses (HHVs) 1 are responsible for diseases ranging from herpes labialis, caused by Herpes simplex virus-1, to Kaposi's sarcoma (KS), caused by Kaposi's sarcoma-associated herpesvirus (KSHV, HHV8) (1) (2) (3) . These nine HHVs are grouped into three families, based on phenotypic and genomic similarities. Although the R-, the -, and the γ-herpesviruses (including KSHV) vary in tissue distribution and disease states, all herpesviruses possess homologous structural and enzymatic proteins involved in their lytic cycles. Among these proteins are the protease (Pr) and assembly protein (AP), which are necessary for infectious virion formation (4) (5) (6) (7) (8) . Pr is expressed as a Pr/AP fusion (9-13), AP binds the major capsid protein, and the complex translocates to the nucleus where the immature capsid is assembled around the AP scaffold (14) . Pr cleaves the Pr/AP fusion at the release site (R-site) and the maturation site (M-site) (10, 11, 13, 15, 16) , allowing DNA packaging, formation of the infectious virion, and completion of the lytic cycle. Additional internal cleavage sites have been identified in multiple herpesvirus proteases; however, KSHV Pr is unique in that autolysis at the D-site (dimer disruption site) leads to inactivation of the protease (17) . D-site cleavage occurs in the virus; however, the significance of autolysis to the KSHV life cycle has yet to be clearly elucidated (18) .
All herpesvirus proteases share a common structure composed of a seven-stranded -barrel surrounded by six R-helices (19) (20) (21) (22) (23) (24) (25) (26) . Herpesvirus proteases require dimerization for activity (17, 18, (27) (28) (29) (30) (31) with binding affinities in the low micromolar to high nanomolar range; however, the dimeric X-ray structures all show the presence of intact active sites in each monomer, which are separate from the dimer interface. Early studies led to the hypothesis that a conformational change connects the active site and dimer interface, linking enzymatic activity to the protein oligomeric state (18, 19, 21, 25, 26, 32, 33) . Recently, NMR spectroscopy and engineering of a redox switch, which allowed protease activity to be controlled by the addition of small molecule effectors (34) , revealed that dissociation of herpesvirus dimers leads to unfolding of the two carboxyl-terminal R-helices. This dimerization-associated conformational change results in disruption of the oxyanion loop and the surprisingly weak dimerization affinity of herpesvirus proteases.
The present study uses circular dichroism (CD), NMR, and a peptide-based phosphonate inhibitor of KSHV Pr to characterize the structural differences between the full-length monomeric, truncated monomeric, and dimeric KSHV Pr and to understand how protease activity is regulated by those conformational changes. Comparison of the dimer and monomer secondary structure using CD allows quantification of differences between the two structures. Measurement of inhibitor binding and reactivity separates the dimerization dependence of substrate binding and turnover on those structural changes. Dimerization controls the reversible activation of all herpesvirus proteases; however, KSHV has evolved a mechanism of irreversible inactivation by autolysis at the internal D-site. D-site cleavage removes helix 6 and leads to irreversible dissociation and inactivation of the resulting truncated protein, referred to as KSHV Pr ∆. The structural and functional consequences of autolytic cleavage are examined by comparison of the NMR chemical shifts and enzymatic activity of the truncated and full-length monomeric proteases. These experiments show that herpesvirus proteases have evolved a switch that stabilizes the transition state machinery, which KSHV Pr exploits at multiple points in the viral life cycle through two different structural rearrangements. These unique control mechanisms are compared to those of well-studied proteolytic enzymes with an emphasis on the similarities in the regulation of structurally diverse proteases.
MATERIALS AND METHODS
Recombinant Expression, Purification, and Quantification of KSHV Protease. A protease variant containing the S204G mutation that is stable to autolysis, referred to as wild-type (WT) protease, a variant containing both the M197D and S204G mutations, referred to as the monomeric or M197D protein, and the truncated protein, KSHV Pr ∆, were expressed in Escherichia coli and purified as previously described (17) . Protease samples incorporating isotopically labeled Asp, Phe, Ile, Leu, Val, or Tyr were recombinantly expressed in E. coli DL39 using M9 media supplemented with the appropriate amino acids. Samples incorporating isotopically labeled Ala, Cys, His, Pro, or Arg were recombinantly expressed in E. coli strain BL21(DE3) in M9 media supplemented with all amino acids, nucleosides, and vitamins (35) 13 C, and 15 N. Protease concentrations were determined using a calculated 280 ) 0.931 mg/mL for wild-type and M197D proteins, 280 ) 1.000 mg/mL for ∆, and 280 ) 0.957 mg/mL for inhibited wild-type protease covalently modified with the inhibitor acetyl-Pro-Val-TyrtBug-Gln-AlaP-(OPh) 2 after hydrolysis of the two phenoxy moieties. The inhibitor was synthesized both with and without a biotin moiety on the amino terminus as previously described (33) .
Fluorescence Polarization. KSHV Pr variants were serially diluted from 10.0 to 0.006 µM in assay buffer (25 mM potassium phosphate, 150 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, pH 8.0) followed by addition of BODIPYlabeled inhibitor (20 nM) and placed in a 384-well plate yielding final protein concentrations of 5.0-0.003 µM and 10 nM fluorescent inhibitor concentration. Measurement of Protease ActiVity. Activity assays were performed in assay buffer (25 mM potassium phosphate, pH 8.0/150 mM potassium chloride/100 µM EDTA/1 mM 2-mercaptoethanol) at 30°C. The Tyr-Val-tBug-Ala-ACC substrate was synthesized and purified as described (36) , and substrate turnover was monitored for 1 h with an excitation wavelength of 380 nm and an emission wavelength of 460 nm. Protease samples were diluted into assay buffer and allowed to equilibrate for at least 1 h. The concentration of dimeric protease was calculated using the previously determined dissociation constant of 1.8 µM and the total concentration of protease using the equation previously derived (33) .
NMR Backbone Resonance Assignments. NMR samples were prepared in NMR buffer (25 mM potassium phosphate, pH 7.0/0.1 mM EDTA/1 mM 2-mercaptoethanol) with D 2 O added to 10% final concentration for deuterium lock. Uniformly labeled protease samples were 0.5-0.7 mM, while selectively labeled samples were between 0.25 and 0.7 mM. All NMR experiments were conducted at 27°C on either a Bruker Avance 500 MHz, a DRX 600 MHz, or an Avance 800 MHz NMR instrument equipped with a triple resonance cryoprobe with Z-axis gradients. All proton chemical shifts were referenced to an internal DSS standard at 0 ppm. Carbon and nitrogen chemical shifts were indirectly referenced to the internal DSS standard using the ratios 0.251449537 and 0.101329118, respectively (37 (39) . All spectra were transformed using the XWINNMR software. Data visualization and spectral assignments used the XEASY (40) and Sparky (41) software packages.
Secondary Structure Measured by Circular Dichroism (CD). CD measurements were performed on a Jasco J-715 spectropolarimeter in 0.1 cm temperature-controlled quartz cuvettes at 27°C. Protease samples were diluted into CD buffer (25 mM potassium phosphate, pH 8.0/1 mM 2-mercaptoethanol) to ∼0.1 mg/mL and allowed to equilibrate for 1 h before measurements. Mean molar residue ellipticities were obtained after solvent spectrum subtraction and 10-fold signal averaging. Secondary structure content was estimated using the self-consistent method contained in the Dicroprot software (42, 43) .
Protein Structure Comparison and Visualization. Graphical representation of chemical shifts, CD, and binding curves were created using Kaleidagraph. All models use Pymol (44) to visualize the structure of KSHV Pr (PDB accession code 1FL1) (25) . All KSHV Pr dimer secondary structure analysis is derived from the above referenced file.
RESULTS

Quantification of Structural Differences between the Monomer and Dimer of KSHV Pr.
Previous experiments have demonstrated that herpesvirus proteases lose secondary structure upon dissociation and that this conformational change results in loss of enzymatic activity (18, 34) . A direct comparison between the monomer and dimer has been conducted through the use of an M197D mutation, which yields inactive monomers, and a hexapeptide diphenyl phosphonate covalent inhibitor, which stabilizes the protease dimer (33) . Comparison of multiple engineered mutations in the KSHV Pr interfacial helix, adjacent to the active site and in the active site, which result in obligate monomers, has shown that loss of dimerization and activity is not linked to any specific point mutant, such as M197D (18; data not shown). The M197D point mutation has been shown to result in obligate monomers, which are structurally indistinct from wild-type monomers isolated at temperatures which allow dimer dissociation (18) . In addition, a monomer containing the M197D substitution as well as a cross-link between helix 6 and the oxyanion loop has proteolytic activity (34) . Taken together, these data strongly suggest that the presence of M197D does not directly disrupt catalysis. CD measurements of the monomeric KSHV Pr variant M197D, the equilibrium mixture of monomeric and dimeric wild-type KSHV Pr, and the completely dimeric inhibited KSHV Pr were collected and are shown in Figure 1a . Secondary structure predictions, based on these measurements, are listed in Table 1 . A related herpesvirus protease and predicted secondary structure from X-ray structures are also listed for comparison. Monomeric KSHV Pr is composed of only 21% R-helix, which is in contrast to the 29% R-helix present in the equilibrium mixture of WT KSHV Pr, at low micromolar concentrations, and the 32% R-helix in completely dimeric KSHV Pr. The increase in R-helical content of the inhibited dimer, compared to the free dimer, is due to the weak dissociation constants of all herpesvirus proteases (1.8 µM for KSHV Pr). Therefore, CD measurements taken at concentrations near the dissociation constant, without the inhibitor, measure a mixture of monomers and dimers. Epstein-Barr virus protease (EBV Pr), a related γ-herpesvirus protease, is also composed of 29% R-helix at low micromolar concentrations (26) . Analysis of the X-ray dimeric structures of KSHV Pr and EBV Pr shows that, when completely dimeric, both proteases should possess 31% R-helicity, consistent with the R-helical content of dimeric, inhibited KSHV Pr as measured by CD (25, 26) .
Use of the inhibitor, which stabilizes the dimeric conformation of KSHV Pr (33) , has allowed the direct comparison of the R-helical content between the monomeric and dimeric conformations of a herpesvirus protease, revealing a loss of 31% R-helicity upon dissociation.
Full-Length and Truncated KSHV Pr Bind but Cannot CleaVe Substrate. CD confirmed earlier NMR experiments and directly measured the loss of R-helical content in the monomer relative to the dimer (34) . Together, these results indicate that only helix 5 and helix 6, which are adjacent to the dimer interface as shown in Figure 1b , are affected by dimerization, while the -barrel and areas distant from the interface are unperturbed by dissociation. These structural studies support earlier evidence that the conformational change is associated with disruption of the catalytic machin- (33) . This result showed that dimeric protease is capable of binding and reacting with substrate. Figure 2 shows a Coomassie-stained gel and streptavidin immunoblot of KSHV Pr variants with or without a biotin-labeled inhibitor. Full-length monomeric KSHV M197D is unable to react with the inhibitor, showing that the catalytic machinery in the monomer is disrupted. Binding of the inhibitor to WT KSHV Pr is evidenced by the shift in molecular weight of the protease in Figure 2 and the labeling of that band with streptavidin-HRP. KSHV Pr ∆ also did not react with the inhibitor (data not shown). Increasing the amount of the monomeric KSHV Pr M197D does not result in any observable reaction with the biotin-labeled inhibitor, further showing that the monomer is unable to react with the transition state mimetic and is unable to turn over substrate.
BODIPY-labeled inhibitor was incubated with varying amounts of full-length monomeric KSHV Pr M197D or the truncated monomer to measure substrate binding, separate from turnover, by fluorescence polarization. These experiments, shown in Figure 3 , reveal that both monomeric forms of KSHV Pr are able to bind the hexapeptide inhibitor. Although the inhibitor only contains the non-prime side of the substrate, the measured binding affinity is tighter than protease dimerization under similar conditions (K d ) 1.8 µM). Additionally, prime-side binding is known to contribute to substrate binding for herpesvirus proteases and would therefore increase the affinity of the substrate. Comparison of the binding affinity of the full-length (260 nM) and truncated monomers (180 nM) shows that autolysis does not substantially affect the binding affinity of the inhibitor. Therefore, both full-length and truncated monomeric KSHV Pr bind substrate with equivalent affinity but cannot catalyze proteolysis.
NMR Backbone Assignments for Characterization of Dimerization-Associated Structural Changes. A recent study used NMR-derived R-carbon chemical shifts to show that helix 5 and helix 6 are disordered in the monomer (34) while X-ray crystallography showed that both helices are well folded in the dimer (25) . NMR was used to directly measure the conformations of both monomeric variants. The present study monitors the proton and nitrogen atoms, as well as the carbon atoms previously studied in the protein backbone, permitting comparison of the conformations of the dimer, full-length monomer, and truncated monomer. The poor solution behavior of KSHV Pr, coupled with its size, precluded the use of most traditional NMR triple resonance experiments for backbone assignments. Despite these limitations, utilization of selected triple resonance experiments, which show linear connectivity of residues through the primary sequence, and amino acid specific labeling (45) (46) (47) (48) resulted in a total of 88% of the assignable backbone amide nitrogen and backbone amide protons in the full-length monomer being identified; 94% of the backbone R carbons and 77% of the backbone carbonyl carbons were also assigned. These alternative assignment methods did not result in the complete assignment of KSHV Pr but did present multiple sources of redundant assignment information, in an analogous manner to well-established purely pulse sequencebased methods, for those assignments that were made. Missing assignments were distributed throughout the protein and did not affect the overall interpretation of the structural changes. Similar analysis of KSHV Pr ∆ resulted in 79% of the assignable backbone amide nitrogen and backbone amide protons and 94% of the backbone R carbons being assigned.
Comparison of Full-Length Monomeric and Truncated InactiVe KSHV Pr. Both monomeric protease forms control proteolysis through the same functional mechanism; however, the conformational changes due to autolysis were still unknown. Comparison of the NMR structures of both fulllength and truncated monomers was conducted to determine if the reversible and irreversible regulation of protease function relied on identical structural determinants. Figure  4a shows a comparison of the heteronuclear single-quantum coherence (HSQC) spectra of KSHV Pr M197D and KSHV Pr ∆. Each HSQC signal corresponds to an amide nitrogen and the attached proton. These signals are sensitive to the environment of each amino acid and can provide insights into changes in protein conformation and molecular interactions. Inspection of the spectral overlay shown in Figure 4a reveals that the spectra are virtually superimposable, indicat-FIGURE 2: The KSHV protease dimer is catalytically active, and the monomer is inactive. Coomassie-stained gel of KSHV Pr variants with and without the addition of biotin-labeled hexapeptide phosphonate inhibitor. Lanes are KSHV Pr S204G -inhibitor, KSHV Pr S204G + inhibitor, KSHV Pr M197D -inhibitor, KSHV Pr M197D + inhibitor, KSHV Pr M197D -inhibitor overloaded, and KSHV Pr M197D + inhibitor overloaded. Immunoblot labeled with streptavidin-HRP with the same lanes as the Coomassiestained gel above, showing only labeled KSHV Pr S204G dimer, which is shifted to a higher molecular weight due to inhibitor binding. Figure  4a indicates; the structures of both monomeric protease forms are nearly identical. A majority of the amino acids have similar chemical shifts in both the full-length and truncated monomer, as evidenced by the fact that 79% of the assigned residues differ in chemical shift by less than the average of the entire protein. Only 35 of the assigned residues have differences in chemical shift, between the full-length and truncated monomers, which exceed the average difference for the entire protein. This fraction of the total amino acids accounts for the conformational changes that occur upon truncation.
Comparison of each chemical shift shows that the greatest differences between the full-length monomer and the truncation occur in helix 5, due to its proximity to the truncation site. (25) . Helix 1 contains greater than average chemical shift differences throughout the length of the helix, which extends from Ser73 to Arg91. The greatest chemical shift changes, and therefore the greatest conformational changes, occur in the amino terminus of helix 1, which is the region closest to helix 5. Helix 2, composed of Glu100 through Leu110, displays chemical shift differences greater than the protein average throughout its length. Additional small changes throughout the protein reflect slight differences in the overall fold; however, due to their small magnitudes relative to the changes in helix 1, helix 2, and helix 5, these changes do not represent the types of substantial changes linked to major conformational differences observed near the dimer disruption site as shown in Figure 4c . It is noteworthy that no changes of similar magnitude to those at the dimer interface occur in the regions of the protease which interact with helix 6 in the full-length dimer, indicating that these regions do not undergo large changes between the two monomeric forms. Comparison of the chemical shifts of fulllength monomeric KSHV Pr M197D and the 203 amino acid C-terminal truncated KSHV Pr ∆ shows isolated differences in structure centered around helix 5, with the remainder of both monomers assuming similar structures.
Dissociation of dimeric herpesvirus proteases leads to destabilization of helix 5 and helix 6. This unfolding event results in loss of the ability to carry out catalytic turnover with retention of the capacity for substrate binding. Autolysis of 27 amino acids, a second mode of enzymatic control, removes helix 6 and disrupts the dimer interface relative to the full-length monomer but does not perturb the remainder of the protein. Truncation also impairs catalytic turnover without disturbing substrate binding relative to the full-length monomer. Therefore, both dissociation and truncation regulate enzymatic activity through similar structural elements and one functional mechanism.
DISCUSSION
Proteases are widespread enzymes that are often tightly regulated due to the catastrophic consequences that result from unchecked proteolysis. Activation and inactivation of proteolysis occur through multiple mechanisms including limited proteolysis, cofactor binding, inhibition, and oligomerization. The unique dimerization-and truncation-linked conformational changes in herpesvirus proteases result in enzymatic regulation through a functional mechanism that is used by many well-known proteolytic systems, specifically transition state stabilization.
Previous studies have shown that herpesvirus proteases are regulated by a dimerization-linked conformational change that disrupts the oxyanion loop necessary for transition state stabilization (18, (32) (33) (34) . Dimerization induces the folding of helix 5 and helix 6, which stabilize the oxyanion hole and contribute to the surprisingly weak binding affinity of these proteases. This conformational change has been quantified through CD measurements that compare a completely dimeric, inhibited protease to the obligate monomeric KSHV Pr M197D. The monomer is shown to contain 31% less R-helicity than the dimer, which is in good agreement with previous NMR studies. This comparison was possible because a transition state mimetic covalently modifies the active site and stabilizes the dimer (33) . This phosphonate inhibitor was also useful for understanding the dimerizationassociated regulation of KSHV Pr function.
The model of dimerization-dependent regulation was divided into two possible regulatory mechanisms: substrate binding and turnover. The isolated dimerization-linked structural changes shown by CD and NMR were expected to only influence substrate turnover; however, it was possible that perturbation of binding determinants could also occur. Fluorescence polarization binding measurements using a transition state mimetic show that monomeric herpesvirus proteases possess a stronger affinity for substrate binding than dimerization. In stark contrast, covalent labeling experiments with the inhibitor and monomeric protease, to test catalytic turnover, revealed a tight link between dimerization and bond cleavage, indicating that monomeric proteases contain disrupted catalytic machinery. These experiments emphasize the importance of the helix 6-oxyanion loop interaction to the mechanism of enzyme regulation. Previous experiments with cytomegalovirus protease (CMV Pr) have shown that perturbation of the dimer interface leads to a reduction in catalytic turnover but not substrate binding (32) . This earlier method for assaying enzymes with low proteolytic activity could not be implemented with monomeric herpesvirus proteases due to the immeasurably low activity of the monomer relative to even mutant dimers. The use of fluorescence polarization and inhibitor labeling allows the functional characterization of even completely inactive monomeric and truncated herpesvirus proteases but would not be appropriate for the characterization of active species.
KSHV Pr is unique among the herpesvirus proteases in that it possesses an inactivating autolysis site within the interfacial helix 5 (17) . Cleavage at this site removes the last turn of helix 5 and all of helix 6, resulting in a completely inactive monomeric species. This cleavage event occurs naturally and represents an irreversible inactivation of the enzyme. The effects of truncation on the structure of KSHV Pr were not clearly known, although earlier CD measurements had shown that the protein does not become completely unfolded (17) . Chemical shift changes between the full-length and truncated monomers show that significant conformational changes occur in helix 5 and extend from the cleavage site at Ala203 beyond helix 5 into the loop connecting helix 4 and helix 5. Helix 5 and the preceding loop assume two different conformations in the full-length and truncated monomers. This difference may be due to the full-length monomeric helix 5, although unwound, continuing to interact with the main body of the protein, while the remainder of helix 5 and the preceding loop in the truncation do not retain this interaction. Additionally, large changes in the conformation of helix 1 and helix 2 are also evident in the truncation. These differences may indicate a shift in the packing of helix 1 relative to the rest of the protein, which would also account for the differences in helix 2, as the two helices are connected through a loop. The structural differences between the truncated and full-length monomers are limited to the dimer interface and adjacent areas. Therefore, the differences between the two monomeric forms are restricted to the same structural elements responsible for the dimerization-associated regulation of KSHV Pr.
Beyond these specific, localized differences, it is noteworthy that the overall structures of the two monomeric protease forms are not drastically different. Of special interest is the lack of large differences between the full-length and truncated protease binding pockets for helix 6, which are the surfaces through which helix 6 stabilizes the oxyanion hole. KSHV Pr ∆ does not possess a helix 6; therefore, the similarity between both monomeric forms indicates that helix 6 does not significantly interact with the main body of the protein in the context of the full-length monomer. This supports earlier evidence of disorder in this region upon disruption of dimerization (32, 34) and further defines the conformational changes linked to dimerization and activation.
Fluorescence polarization measurements and inhibitor binding assays of KSHV Pr ∆ show that truncation does not affect substrate binding relative to the full-length monomer and that KSHV Pr ∆ is also unable to turn over substrate. This similarity is expected, based on the NMR comparison of the two forms. Substrate binding is known to be mediated through the -barrel and loops distant from the dimer interface, which are not affected by truncation, and KSHV Pr ∆ should therefore bind the inhibitor with equivalent affinity to the full-length monomer. KSHV Pr appears to take advantage of the mechanism already in place for protease activation to also inactivate the enzyme through autolysis. Therefore, irreversible inactivation of KSHV Pr through autolytic truncation and reversible activation and inactivation of herpesvirus proteases by dimerization, two very different structural changes, both regulate enzymatic activity through the functional mechanism of transition state stabilization mediated by the helix 6-oxyanion loop interaction.
Spatial and temporal restrictions of proteolytic activity are not limited to herpesvirus proteases. Although herpesvirus proteases use a unique conformational change to regulate activity, the functional mechanisms employed are used by other structurally unrelated proteases. KS is the most common cancer in AIDS patients, and the viruses responsible for both of these devastating diseases, although structurally unrelated, share similar functional regulatory mechanisms. HIV protease is also regulated by dimerization and contains inactivating internal autolysis sites (49) (50) (51) . Regulation of HIV protease is necessary for virion formation. Perturbation of dimerization-linked activation results in premature processing of viral proteins, disruption of the viral life cycle, and cellular toxicity (52) . Cellular toxicity is thought to result from cleavage of cellular proteins by the unregulated HIV protease, which is normally controlled by dimerization and autolytic inactivation. A necessity for autolysis has been shown in a related herpesvirus protease. The importance of D-site cleavage to the KSHV Pr lytic cycle is currently unknown; however, two different autolysis sites in CMV Pr have been shown to be important for virion formation and infectivity (53) . Prevention of autolysis results in a 90% reduction in virus production. Although these two sites do not correspond to the D-site, one site may result in loss of helix 5 and helix 6 in the same way as D-site cleavage.
Herpesvirus protease regulation also shares characteristics with many nonviral proteases including trypsin, one of the most extensively studied proteases. Dimerization of herpesvirus proteases stabilizes the oxyanion loop, and in a similar fashion, the conversion of trypsinogen to trypsin also results in the organization of the oxyanion hole. Oxyanion hole stabilization is a mechanism of protease regulation which is widely utilized. Trypsin and other pancreatic proteases also possess inactivating autolysis sites, which have been shown to be important in the proper spatial regulation of activity. Similar parallels can be drawn between the control of KSHV Pr and the complement convertases, caspases, and coagulation proteases. These comparisons show that although proteases assume diverse structures, they can be regulated by a limited set of unifying mechanisms.
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